$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

1H-Imidazo[4,5-c]quinolin-4-amines and antiviral use 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C07D-471/04
  • A61K-031/47
출원번호 US-0798385 (1985-11-15)
발명자 / 주소
  • Gerster John F. (Woodbury MN)
출원인 / 주소
  • Riker Laboratories, Inc. (St. Paul MN 02)
인용정보 피인용 횟수 : 305  인용 특허 : 4

초록

1H-Imidazo[4,5-c]quinolin-4-amines which are antivirals. Pharmacological methods of using such compounds and pharmaceutical compositions containing such compounds are also described.

대표청구항

A compound of the formula [Figure] wherein R1 is selected from the group consisting of alkyl of one to about ten carbon atoms, hydroxylalkyl of one to about six carbon atoms, acyloxyalkyl wherein the acyloxy moiety is alkanoyloxy of two to about four carbon atoms or benzoyloxy, and the alkyl moiety

이 특허에 인용된 특허 (4)

  1. Warner ; Jr. Paul L. (Clarence NY) Luber ; Jr. Edward J. (Buffalo NY), 4-Aminosubstituted imidazo(1,2-A)quinoxalines.
  2. Treuner Uwe D. (Regensburg DT), 4-Substituted derivatives of pyrazolo [1,5-a]-quinoxaline-3-carboxylic acids and esters.
  3. Crenshaw Ronnie Ray (Dewitt NY) Luke George Michael (Lafayette NY) Siminoff Paul (Dewitt NY), Antiviral, substituted 1,3-dimethyl-1H-pyrazolo(3,4b)quinolines.
  4. Warner ; Jr. Paul L. (Clarence NY) Luber ; Jr. Edward J. (Buffalo NY), Method for treating fungal infection in mammals with imidazo [1,2-a]quinoxalines.

이 특허를 인용한 특허 (305)

  1. Griesgraber,George W.; Manske,Karl J., 1-Amino 1H-imidazoquinolines.
  2. Krepski, Larry R.; Duffy, Daniel E.; Gerster, John F.; Moseman, Joan T., 1-alkoxy 1H-imidazo ring systems and methods.
  3. Gerster John F. ; Crooks Stephen L. ; Lindstrom Kyle J., 1-substituted, 2-substituted 1H-imidazo[4,5-c] quinolin-4-amines.
  4. John F. Gerster ; Stephen L. Crooks ; Kyle J. Lindstrom, 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines.
  5. Merli,Valeriano; Mantovani,Silvia; Bianchi,Stefano, 1H-imidazo [4,5-c] quinolin-4-cyano and 1H-imidazo [4,5-c] quinolin-4-carboxamide intermediates.
  6. Griesgraber, George W., 1H-imidazo dimers.
  7. Griesgraber,George W., 1H-imidazo dimers.
  8. Miller Richard L. ; Tomai Mark A. ; Bernstein David I. ; Harrison Christopher J., 1H-imidazo[4,5-C]quinolin-4-amines as vaccine adjuvants.
  9. Garcia-Echeverria, Carlos; Capraro, Hans-Georg; Furet, Pascal, 1H-imidazo[4,5-c]quinoline derivatives in the treatment of protein kinase dependent diseases.
  10. Kato, Hideo; Sakaguchi, Jun; Aoyama, Makoto; Izumi, Tomoyuki; Kato, Ken-ichi, 1H-imidazopyridine derivatives.
  11. Kshirsagar, Tushar A.; Langer, Scott E.; Niwas, Shri; Heppner, Philip D.; Amos, David T., 2-amino 1H-in-imidazo ring systems and methods.
  12. Lindstrom, Kyle J., 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]napthyridin-4 amine.
  13. Takada Susumu (Hyogo JPX) Fujishita Toshio (Osaka JPX) Sasatani Takashi (Nara JPX) Matsushita Akira (Hyogo JPX) Eigyo Masami (Nara JPX), 2-substituted carbonylimidazo[4,5-c]quinolines.
  14. Nordsiek, Michael T.; Levy, Sharon F.; Lee, James Hurn-Joung; Kulp, James H.; Balaji, Kodumudi S.; Meng, Tze-Chiang; Wu, Jason J.; Bahm, Valyn S.; Babilon, Robert, 2×2×2 week dosing regimen for treating acting keratosis with pharmaceutical compositions formulated with 3.75% imiquimod.
  15. Nordsiek, Michael T.; Levy, Sharon F.; Lee, James H.; Kulp, James H.; Balaji, Kodumudi S.; Meng, Tze-Chiang; Wu, Jason J.; Bahm, Valyn S.; Babilon, Robert, 2×2×2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75 % imiquimod.
  16. Nordsiek, Michael T.; Levy, Sharon F.; Lee, James H.; Kulp, James H.; Balaji, Kodumudi S.; Meng, Tze-Chiang; Wu, Jason J.; Bahm, Valyn S.; Babilon, Robert, 2×2×2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75 % imiquimod.
  17. Nordsiek, Michael T.; Levy, Sharon F.; Lee, James H.; Kulp, James H.; Balaji, Kodumudi S.; Meng, Tze-Chiang; Wu, Jason J.; Bahm, Valyn S.; Babilon, Robert, 2×2×2 week treatment regimen for treating actinic keratosis with pharmaceutical compositions formulated with 2.5% imiquimod.
  18. Galatsis, Paul; Hayward, Matthew Merrill; Kormos, Bethany Lyn; Wager, Travis T.; Zhang, Lei; Henderson, Jaclyn Louise; Kurumbail, Ravi G.; Verhoest, Patrick Robert; Stepan, Antonia Friederike, 3,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7H-pyrrolo[2,3-c]pyridazines as LRRK2 inhibitors.
  19. Andr Jean-Denis (Pithiviers FRX) Lagain Daniel (Dadonville FRX), 3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines.
  20. Cook, Anthony; McInally, Tom; Thom, Stephen; Wada, Hiroki, 8-oxoadenine derivatives acting as modulators of TLR7.
  21. Kurimoto, Ayumu; Hashimoto, Kazuki; Isobe, Yoshiaki; Brough, Stephen; Millichip, Ian; Wada, Hiroki; Bonnert, Roger; Mcinally, Thomas, 9-substituted 8-oxoadenine compound.
  22. Kurimoto, Ayumu; Hashimoto, Kazuki; Isobe, Yoshiaki; Brough, Stephen; Millichip, Ian; Wada, Hiroki; Bonnert, Roger; Mcinally, Thomas, 9-substituted 8-oxoadenine compound.
  23. Kurimoto, Ayumu; Isobe, Yoshiaki; Brough, Stephen; Wada, Hiroki; Bonnert, Roger; McInally, Thomas, 9-substituted 8-oxoadenine compound.
  24. Bonnert, Roger Victor; McInally, Thomas; Thom, Stephen, 9-substituted-8-oxo-adenine compounds as toll-like receptor (TLR7 ) modulators.
  25. Bonnert, Roger Victor; McInally, Thomas; Thom, Stephen, 9-substituted-8-oxo-adenine compounds as toll-like receptor (TLR7) modulators.
  26. Isobe, Yoshiaki; Nakamura, Tomoaki, Adenine compound.
  27. Isobe, Yoshiaki; Takaku, Haruo; Ogita, Haruhisa; Tobe, Masanori; Kurimoto, Ayumu; Ogino, Tetsuhiro; Fujita, Hitoshi, Adenine compound and use thereof.
  28. Isobe, Yoshiaki; Takaku, Haruo; Ogita, Haruhisa; Tobe, Masanori; Kurimoto, Ayumu; Ogino, Tetsuhiro; Fujita, Hitoshi, Adenine compound and use thereof.
  29. Isobe, Yoshiaki; Ogita, Haruhisa; Tobe, Masanori; Takaku, Haruo; Ogino, Tetsuhiro; Kurimoto, Ayumu; Kawakami, Hajime, Adenine derivatives.
  30. Isobe,Yoshiaki; Ogita,Haruhisa; Tobe,Masanori; Takaku,Haruo; Ogino,Tetsuhiro; Kurimoto,Ayumu; Kawakami,Hajime, Adenine derivatives.
  31. Cantor Adam S. ; Choi Hye-ok ; Delgado Joaquin ; Ko Chan U. ; Tran Thu-Van, Adhesive microsphere drug delivery composition.
  32. Lindstrom, Kyle J.; Merrill, Bryon A.; Haraldson, Chad A.; Rice, Michael J.; Kshirsagar, Tushar A.; Heppner, Philip D.; Wurst, Joshua R.; Niwas, Shri; Johannessen, Sarah C., Alkoxy substituted imidazoquinolines.
  33. Lindstrom, Kyle J.; Merrill, Bryon A.; Haraldson, Chad A.; Rice, Michael J.; Kshirsagar, Tushar A.; Heppner, Philip D.; Wurst, Joshua R.; Niwas, Shri; Slania, Sarah J., Alkoxy substituted imidazoquinolines.
  34. Lindstrom, Kyle J.; Merrill, Bryon A.; Haraldson, Chad A.; Rice, Michael J.; Kshirsagar, Tushar A.; Heppner, Philip D.; Wurst, Joshua R.; Niwas, Shri; Slania, Sarah J., Alkoxy substituted imidazoquinolines.
  35. Prince, Ryan B.; Merrill, Bryon A.; Heppner, Philip D.; Kshirsagar, Tushar A.; Wurst, Joshua R.; Manske, Karl J.; Rice, Michael J., Alkyloxy substituted thiazoloquinolines and thiazolonaphthyridines.
  36. Kshirsagar, Tushar A.; Niwas, Shri; Merrill, Bryon A., Amide and carbamate derivatives of N-{2-[4-amino-2-(ethoxymethyl)-1H-imidazo[4,5-c] quinolin-1-Yl]-1,1-dimethylethyl}methanesulfonamide and methods.
  37. Kshirsagar, Tushar A.; Niwas, Shri; Merrill, Bryon A., Amide and carbamate derivatives of alkyl substituted N-[4-(4-amino-1H-imidazo[4,5-c]quinolin-1-yl)butyI]methanesulfonamides and methods.
  38. Dellaria, Joseph F.; Haraldson, Chad A.; Heppner, Philip D.; Lindstrom, Kyle J.; Merrill, Bryon A., Amide substituted imidazopyridines.
  39. Dellaria, Joseph F.; Haraldson, Chad A.; Heppner, Philip D.; Lindstrom, Kyle J.; Merrill, Bryon A., Amide substituted imidazopyridines.
  40. Dellaria, Joseph F.; Haraldson, Chad A.; Lindstrom, Kyle J.; Merrill, Bryon A., Amide substituted imidazopyridines.
  41. Heppner, Philip D.; Lindstrom, Kyle J.; Merrill, Bryon A., Amide substituted imidazopyridines.
  42. Heppner,Philip D.; Lindstrom,Kyle J.; Merrill,Bryon A., Amide substituted imidazopyridines.
  43. Krepski, Larry R.; Dellaria, Jr., Joseph F.; Duffy, Daniel E.; Amos, David T.; Zimmermann, Bernhard M.; Moser, William H., Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines.
  44. Coleman, Patrick L.; Crooks, Stephen L.; Griesgraber, George W.; Lindstrom, Kyle J.; Merrill, Bryon A.; Rice, Michael J., Amide substituted imidazoquinolines.
  45. Coleman,Patrick L.; Crooks,Stephen L.; Griesgraber,George W.; Lindstrom,Kyle J.; Merrill,Bryon A.; Rice,Michael J., Amide substituted imidazoquinolines.
  46. Patrick L. Coleman ; Stephen L. Crooks ; Kyle J. Lindstrom ; Bryon A. Merrill ; Michael J. Rice, Amide substituted imidazoquinolines.
  47. Crooks, Stephen L.; Griesgraber, George W.; Heppner, Philip D.; Merrill, Bryon A., Amido ether substituted imidazoquinolines.
  48. Crooks, Stephen L.; Griesgraber, George W.; Heppner, Philip D.; Merrill, Byron A., Amido ether substituted imidazoquinolines.
  49. Crooks,Stephen L.; Griesgraber,George W.; Heppner,Philip D.; Merrill,Bryon A., Amido ether substituted imidazoquinolines.
  50. Phull, Manjinder Singh; Kankan, Rajendra Narayanrao; Rao, Dharmaraj Ramachandra, Antiviral phosphonate analogues and process for preparation thereof.
  51. Ma, David Q.; Perman, Christopher S.; Skwierczynski, Raymond D.; Hedenstrom, John C., Aqueous gel formulations containing immune response modifiers.
  52. Perman, Christopher S.; Skwierczynski, Raymond D.; Ma, David Q.; Hedenstrom, John C., Aqueous gel formulations containing immune response modifiers.
  53. Charles, Leslie J.; Dellaria, Joseph F.; Heppner, Philip D.; Merrill, Bryon A.; Mickelson, John W., Aryl ether substituted imidazoquinolines.
  54. Dellaria, Joseph F.; Mickelson, John W., Aryl ether substituted imidazoquinolines.
  55. Heppner, Phillip D.; Charles, Leslie J.; Dellaria, Joseph F.; Merrill, Bryon A.; Mickelson, John W., Aryl ether substituted imidazoquinolines.
  56. Heppner,Philip D.; Charles,Leslie J.; Dellaria,Joseph F.; Merrill,Bryon A.; Mickelson,John W., Aryl ether substituted imidazoquinolines.
  57. Hays,David S.; Niwas,Shri; Kshirsagar,Tushar; Heppner,Philip D.; Merrill,Bryon A.; Danielson,Michael E.; Gerster,John F.; Haraldson,Chad A.; Kavanagh,Maureen A.; Rice,Michael J.; Strong,Sarah A.; Wur, Aryl substituted Imidazoquinolines.
  58. Niwas, Shri; Merrill, Bryon A.; Heppner, Philip D.; Kshirsagar, Tushar A.; Lundquist, Jr., Gregory D.; Amos, David T.; Lindstrom, Kyle J., Aryl substituted imidazonaphthyridines.
  59. Hays, David S.; Kshirsagar, Tushar; Heppner, Philip D.; Merrill, Bryon A.; Danielson, Michael E.; Gerster, John F.; Haraldson, Chad A.; Johannessen, Sarah; Kavanagh, Maureen A.; Lindstrom, Kyle J.; Rice, Michael J.; Squire, David J.; Strong, Sarah A.; Wurst, Joshua R., Aryl substituted imidazoquinolines.
  60. Bonk, Jason D.; Dellaria, Jr., Joseph F., Arylalkenyl and arylalkynyl substituted imidazoquinolines.
  61. Lindstrom, Kyle J.; Martin, Hugues M. H.; Merrill, Bryon A.; Rice, Michael J.; Wurst, Joshua R.; Haraldson, Chad A.; Heppner, Philip D.; Niwas, Shri; Radmer, Matthew R., Aryloxy and arylalkyleneoxy substituted imidazoquinolines.
  62. Lindstrom, Kyle J.; Martin, Hugues M. H.; Merrill, Bryon A.; Rice, Michael J.; Wurst, Joshua R.; Haraldson, Chad A.; Kshirsagar, Tushar A.; Heppner, Philip D.; Niwas, Shri; Griesgraber, George W.; Radmer, Matthew R., Aryloxy and arylalkyleneoxy substituted imidazoquinolines.
  63. Prince, Ryan B.; Rice, Michael J.; Wurst, Joshua R.; Merrill, Bryon A.; Kshirsagar, Tushar A.; Heppner, Philip D., Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines.
  64. Hori, Seiji; Hasegawa, Futoshi; Urabe, Daisuke; Kurebayashi, Hirotaka, Carboxylic acid compounds.
  65. Hori, Seiji; Hasegawa, Futoshi; Urabe, Daisuke; Kurebayashi, Hirotaka, Carboxylic acid compounds.
  66. Griesgraber, George W.; Kshirsagar, Tushar A.; Celebi, Azim A.; Slania, Sarah J.; Danielson, Michael E.; Rice, Michael J.; Wurst, Joshua R., Chiral fused [1,2]imidazo[4,5-c] ring compounds.
  67. Griesgraber, George W.; Slania, Sarah J., Chiral fused [1,2]imidazo[4,5-c] ring compounds.
  68. Mohanty, Sanat; Moran, Cristin E.; Sahouani, Hassan; Boardman, Larry D., Chromonic nanoparticles containing bioactive compounds.
  69. Gold, Michael H.; Cohen, Joel L.; Munavalli, Girish S.; Meng, Tze-Chiang, Combination therapy with low dosage strength imiquimod and photodynamic therapy to treat actinic keratosis.
  70. Dickey, Burton; Tuvim, Michael; Evans, Scott, Compositions for stimulation of mammalian innate immune resistance to pathogens.
  71. Dickey, Burton; Tuvim, Michael; Evans, Scott, Compositions for stimulation of mammalian innate immune resistance to pathogens.
  72. Dickey, Burton; Tuvim, Michael; Evans, Scott, Compositions for stimulation of mammalian innate immune resistance to pathogens.
  73. Bennett, Nicholas J.; McInally, Thomas; Thom, Stephen, Compounds.
  74. Bonnert, Roger Victor; McInally, Thomas; Mochel, Tobias; Thom, Stephen, Compounds.
  75. Wu, Tom Yao Hsiang; Li, Yongkai; Cortez, Alex; Zou, Yefen; Mishra, Pranab; Zhang, Xiaoyue; Skibinski, David; Singh, Manmohan; Valiante, Nicholas, Compounds and compositions as TLR activity modulators.
  76. Wu, Tom Yao-Hsiang; Li, Yongkai; Cortez, Alex; Zou, Yefen; Mishra, Pranab; Zhang, Xiaoyue; Valiante, Nicholas, Compounds and compositions as TLR activity modulators.
  77. Lioux, Thierry; Drocourt, Daniel; Vernejoul, Fabienne; Tiraby, Gerard; Perouzel, Eric, Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists.
  78. Carson, Dennis A.; Cottam, Howard B.; Wrasidlo, Wolfgang; Wu, Christina C. N.; Daniels, Gregory A., Conjugates of synthetic TLR agonists and uses therefor.
  79. Carson, Dennis A.; Cottam, Howard B.; Wrasidlo, Wolfgang; Wu, Christina C. N.; Daniels, Gregory A., Conjugates of synthetic TLR agonists and uses therefor.
  80. Carson, Dennis A.; Wrasidlo, Wolfgang; Wu, Christina C. N., Conjugates of synthetic TLR agonists and uses therefor.
  81. Wolter, James T.; Kedl, Ross M., Delivery of immune response modifier compounds.
  82. Michael J. Rice ; Mark A. Tomai ; Ai-Ping Wei, Dye labeled imidazoquinoline compounds.
  83. Rice, Michael J.; Tomai, Mark A.; Wei, Ai-Ping, Dye labeled imidazoquinoline compounds.
  84. Rice, Michael J.; Tomai, Mark A.; Wei, Ai-Ping, Dye labeled imidazoquinoline compounds.
  85. Dellaria, Joseph F.; Lindstrom, Kyle J.; Dressel, Luke T.; Heppner, Philip D.; Jacobsen, John R.; Radmer, Matthew R.; Stoermer, Doris, Ether substituted imidazopyridines.
  86. Dellaria,Joseph F.; Lindstrom,Kyle J.; Dressel,Luke T.; Duffy,Daniel E.; Heppner,Philip D.; Jacobsen,John R.; Moseman,Joan T.; Moser,William H.; Radmer,Matthew R.; Stoermer,Doris; Zimmermann,Bernhard, Ether substituted imidazopyridines.
  87. Dellaria,Joseph F.; Lindstrom,Kyle J.; Dressel,Luke T.; Heppner,Philip D.; Jacobsen,John R.; Moseman,Joan T.; Moser,William H.; Radmer,Matthew R.; Stoermer,Doris, Ether substituted imidazopyridines.
  88. Noelle, Randolph J.; Ahonen, Cory L.; Kedl, Ross M., Ex vivo uses of immunostimulatory combinations.
  89. Abram, Albert Zorko; Goldstein, Iulian, Fatty acid pharmaceutical foam.
  90. Abram, Albert Zorko; Goldstein, Iulian, Fatty acid pharmaceutical foam.
  91. Raymond D. Skwierczynski ; Kenneth R. Phares ; Richard L. Miller ; Zheng Jane Li ; Michael J. Jozwiakowski ; Terri F. Busch, Formulations and methods for treatment of mucosal associated conditions with an immune response modifier.
  92. Skwierczynski Raymond D. ; Phares Kenneth R. ; Miller Richard L. ; Li Zheng Jane ; Jozwiakowski Michael J. ; Busch Terri F., Formulations and methods for treatment of mucosal associated conditions with an immune response modifier.
  93. Hammerbeck, David M.; Guy, Cynthia A.; Leung, Suzanne S, Formulations containing an immune response modifier.
  94. Nikolaides Nick ; Gerster John F., Fused cycloalkylimidazopyridines.
  95. Beaurline Joseph M. ; Roddy Patrick J. ; Tomai Mark A., Gel formulations for topical drug delivery.
  96. Joseph M. Beaurline ; Patrick J. Roddy ; Mark A. Tomai, Gel formulations for topical drug delivery.
  97. Griesgraber, George W., Guanidine substituted imidazo[4,5-c] ring compounds.
  98. Wightman, Paul D., Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom.
  99. Wightman, Paul D., Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom.
  100. Charles, Leslie J.; Dellaria, Joseph F.; Griesgraber, George W.; Heppner, Philip D.; Manske, Karl J.; Mickelson, John W.; Rice, Michael J., Heterocyclic ether substituted imidazoquinolines.
  101. Yu, Chongxi; Xu, Lina, High penetration compositions and uses thereof.
  102. Yu, Chongxi, High penetration prodrug compositions of 1H-imidazo[4,5-C]quinolin-4-amines and 1H-imidazo[4,5-C]quinolin-4-amine-related compounds.
  103. Yu, Chongxi, High penetration prodrug compositions of 1H-imidazo[4,5-c]quinolin-4-amines and 1H-imidazo[4,5-c]quinolin-4-amine-related compounds and uses thereof.
  104. Wightman, Paul D., Hydrazino 1H-imidazoquinolin-4-amines and conjugates made therefrom.
  105. Wightman, Paul D., Hydrazino 1H-imidazoquinolin-4-amines and conjugates made therefrom.
  106. Kshirsagar, Tushar A.; Langer, Scott E., Hydroxy and alkoxy substituted 1H-imidazonaphthyridines and methods.
  107. Kshirsagar, Tushar A.; Heppner, Philip D.; Langer, Scott E., Hydroxy and alkoxy substituted 1H-imidazoquinolines and methods.
  108. Kshirsagar, Tushar A.; Heppner, Philip D.; Langer, Scott E., Hydroxy and alkoxy substituted 1H-imidazoquinolines and methods.
  109. Kshirsagar, Tushar A.; Langer, Scott E.; Niwas, Shri; Griesgraber, George W.; Heppner, Philip D.; Lindstrom, Kyle J., Hydroxyalkyl substituted imidazonaphthyridines.
  110. Kshirsagar, Tushar A.; Merrill, Bryon A.; Niwas, Shri; Lundquist, Jr., Gregory D.; Heppner, Philip D.; Danielson, Michael E., Hydroxyalkyl substituted imidazoquinoline compounds and methods.
  111. Kshirsagar, Tushar A.; Merrill, Bryon A.; Langer, Scott E.; Lindstrom, Kyle J.; Slania, Sarah J.; Marszalek, Gregory J.; Manske, Karl J.; Heppner, Philip D.; Lundquist, Jr., Gregory D., Hydroxyalkyl substituted imidazoquinolines.
  112. Krepski, Larry R.; Dellaria, Jr., Joseph F.; Marszalek, Gregory J., Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines.
  113. Kshirsagar, Tushar A.; Amos, David T.; Dellaria, Jr., Joseph F.; Heppner, Philip D.; Langer, Scott E.; Zimmermann, Bernhard M., Hydroxylamine substituted imidazoquinolines.
  114. Kshirsagar, Tushar A.; Lundquist, Jr., Gregory D.; Amos, David T.; Dellaria, Jr., Joseph F.; Zimmermann, Bernhard M.; Heppner, Philip D., Hydroxylamine substituted imidazoquinolines.
  115. Griesgraber, George W., Imidazo[4,5-c] ring compounds containing substituted guanidine groups.
  116. Coffman, Karen Jean; Galatsis, Paul; Garnsey, Michelle Renee; Henderson, Jaclyn Louise; Kormos, Bethany Lyn; Kurumbail, Ravi G.; Pettersson, Martin Youngjin; Reese, Matthew Richard; Stepan, Antonia Friederike; Verhoest, Patrick Robert; Wager, Travis T., Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives as LRRK2 inhibitors.
  117. Gerster John F. ; Lindstrom Kyle J. ; Crooks Stephen L. ; Heppner Philip D. ; Marszalek Gregory J. ; Maye Peter V. ; Merrill Bryon A. ; Mickelson John W. ; Rice Michael J., Imidazonaphthyridines.
  118. Gerster, John F.; Lindstrom, Kyle J., Imidazonaphthyridines.
  119. Gerster, John F.; Lindstrom, Kyle J.; Crooks, Stephen L.; Heppner, Philip D.; Marszalek, Gregory J.; Maye, Peter V.; Merrill, Bryon A.; Mickelson, John W.; Rice, Michael J., Imidazonaphthyridines.
  120. Gerster, John F.; Lindstrom, Kyle J.; Crooks, Stephen L.; Heppner, Philip D.; Marszalek, Gregory J.; Maye, Peter V.; Merrill, Bryon A.; Mickelson, John W.; Rice, Michael J., Imidazonaphthyridines.
  121. Gerster, John F.; Lindstrom, Kyle J.; Crooks, Stephen L.; Heppner, Philip D.; Marszalek, Gregory J.; Maye, Peter V.; Merrill, Bryon A.; Mickelson, John W.; Rice, Michael J., Imidazonaphthyridines.
  122. Gerster, John F.; Lindstrom, Kyle J.; Crooks, Stephen L.; Heppner, Philip D.; Marszalek, Gregory J.; Maye, Peter V.; Merrill, Bryon A.; Mickelson, John W.; Rice, Michael J., Imidazonaphthyridines.
  123. Gerster,John F.; Lindstrom,Kyle J.; Crooks,Stephen L.; Heppner,Philip D.; Marszalek,Gregory J.; Maye,Peter V.; Merrill,Bryon A.; Mickelson,John W.; Rice,Michael J., Imidazonaphthyridines.
  124. Lindstrom, Kyle J.; Merrill, Bryon A.; Rice, Michael J., Imidazonaphthyridines.
  125. Lindstrom, Kyle J.; Rice, Michael J., Imidazonaphthyridines.
  126. Lindstrom, Kyle J.; Rice, Michael J., Imidazonaphthyridines.
  127. Mickelson, John W., Imidazonaphthyridines.
  128. McInally, Thomas; Pimm, Austen, Imidazoquinoline compounds.
  129. Bonnert, Roger Victor; McInally, Thomas; Thom, Stephen; Wada, Hiroki, Imidazoquinolines with immuno-modulating properties.
  130. Bonk, Jason D.; Dellaria, Jr., Joseph F., Imidazoquinolinyl sulfonamides.
  131. Suzuki Fumio (Mishima JPX) Kuroda Takeshi (Shizuoka JPX) Nakazato Yoshisuke (Shizuoka JPX) Ohmori Kenji (Mishima JPX) Manabe Haruhiko (Shizuoka JPX), Imidazoquinolone derivatives.
  132. Sutton, James; Xu, Feng; Valiante, Nicholas; Lan, Jiong, Imidazoquinoxaline compounds as immunomodulators.
  133. Naddaka, Vladimir; Saeed, Shady; Cherkez, Stephen; Arad, Oded, Imiquimod production process.
  134. Tomai Mark A. ; Hammerbeck David M. ; Swingle Karl F., Immine response modifier compounds for treatment of TH2 mediated and related diseases.
  135. Stoermer, Doris; Griesgraber, George W.; Kshirsagar, Tushar A., Immune response modifier compositions and methods.
  136. Stoermer, Doris; Griesgraber, George W.; Kshirsagar, Tushar A., Immune response modifier compositions and methods.
  137. Stoesz, James D.; Statham, Alexis S.; Truong, Myhanh T., Immune response modifier compositions and methods.
  138. Tomai Mark A. ; Hammerbeck David M. ; Swingle Karl F., Immune response modifier compounds for treatment of TH2 mediated and related diseases.
  139. Tomai, Mark A.; Hammerbeck, David M.; Swingle, Karl F., Immune response modifier compounds for treatment of TH2 mediated and related diseases.
  140. Tomai, Mark A.; Hammerbeck, David M.; Swingle, Karl F., Immune response modifier compounds for treatment of TH2 mediated and related diseases.
  141. Stoermer, Doris; Griesgraber, George W.; Mendoza, James D.; Bonk, Jason D., Immune response modifier conjugates.
  142. Statham, Alexis S.; Nelson, Robert J., Immune response modifier formulations containing oleic acid and methods.
  143. Statham, Alexis S.; Nelson, Robert J., Immune response modifier formulations containing oleic acid and methods.
  144. Sutton, James; Valiante, Nicholas, Immunopotentiating compounds.
  145. Lipford, Grayson B.; Bauer, Stefan; Wagner, Hermann, Immunostimulatory G, U-containing oligoribonucleotides.
  146. Lipford, Grayson B.; Bauer, Stefan; Wagner, Hermann, Immunostimulatory G, U-containing oligoribonucleotides.
  147. Lipford, Grayson; Bauer, Stefan; Wagner, Hermann, Immunostimulatory G, U-containing oligoribonucleotides.
  148. Noelle, Randolph J.; Ahonen, Cory L.; Kedl, Ross M., Immunostimulatory combinations.
  149. Noelle,Randolph J.; Ahonen,Cory L.; Kedl,Ross M., Immunostimulatory combinations.
  150. Kedl,Ross M.; Griesgraber,George W.; Zarraga,Isidro Angelo E.; Wightman,Paul D., Immunostimulatory compositions and methods of stimulating an immune response.
  151. Nikolaides Nick (Woodbury MN) Gerster John F. (Woodbury MN), Intermediate compounds of fused cycloalkylimidazopyridines.
  152. Gerster, John F.; Lindstrom, Kyle J.; Crooks, Stephen L.; Heppner, Philip D.; Marszalek, Gregory J.; Maye, Peter V.; Merrill, Bryon A.; Mickelson, John W.; Rice, Michael J., Intermediates for imidazonaphthyridines.
  153. Gerster,John F.; Lindstrom,Kyle J.; Crooks,Stephen L.; Heppner,Philip D.; Marszalek,Gregory J.; Maye,Peter V.; Merrill,Bryon A.; Mickelson,John W.; Rice,Michael J., Intermediates for imidazonaphthyridines.
  154. Wightman, Paul D., Lipid-modified immune response modifiers.
  155. Wightman, Paul D., Lipidated immune response modifier compound compositions, formulations, and methods.
  156. Wightman, Paul D., Lipidated immune response modifier compound compositions, formulations, and methods.
  157. Wightman, Paul D., Lipidated immune response modifier compound compositions, formulations, and methods.
  158. Nordsiek, Michael T.; Gregory, Jefferson J., Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts.
  159. Nordsiek, Michael T.; Gregory, Jefferson J., Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts.
  160. Nordsiek, Michael T.; Gregory, Jefferson J., Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts.
  161. Nordsiek, Michael T.; Gregory, Jefferson J., Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts.
  162. Sallares, Juan; Petschen, Inés; Camps, Francesc-Xavier, Method for making 1-substituted 1H-imidazo [4,5-C] quinolin-4-amine compounds and intermediates therefor.
  163. Moran, Cristin E.; Sahouani, Hassan; Boardman, Larry D.; Mohanty, Sanat, Method for making chromonic nanoparticles.
  164. Slade, Herbert B., Method for the treatment of dermal lesions caused by envenomation.
  165. Baumann, Leslie; Welsh, Esperanza, Method for treating damaged skin.
  166. Scherrer, Lawrence C., Method of inhibiting growth of neoplastic cells and inhibiting infection by administering an immune enhancer drug.
  167. Kshirsagar, Tushar A.; Merrill, Bryon A.; Langer, Scott E.; Lindstrom, Kyle J.; Slania, Sarah C.; Marszalek, Gregory J.; Wurst, Joshua R.; Manske, Karl J.; Niwas, Shri; Lundquist, Jr., Gregory D.; Heppner, Philip D.; Griesgraber, George W.; Danielson, Michael E., Method of preferentially inducing the biosynthesis of interferon.
  168. Gutman, Daniella; Baidossi, Wael; Chernyak, Shimon, Method of preparing 4-amino-1-imidazo(4,5-)quinolines and acid addition salts thereof.
  169. Miller,Richard L.; Gaspari,Anthony A.; Gillis,Joseph A., Method of reducing and treating UVB-induced immunosuppression.
  170. Graham,Paul D.; Elliott,Peter T.; Gallagher,Kevin G., Method of tattoo removal.
  171. Lee, James H.; Fox, Terrance L., Method of treating actinic keratosis.
  172. Nordsiek, Michael T.; Levy, Sharon F.; Lee, James H.; Kulp, James H.; Balaji, Kodumudi S.; Meng, Tze-Chiang; Wu, Jason J.; Bahm, Valyn S.; Babilon, Robert, Method of treating actinic keratosis with 3.75% imiquimod cream.
  173. Nordsiek, Michael T.; Levy, Sharon F.; Lee, James H.; Kulp, James H.; Balaji, Kodumudi S.; Meng, Tze-Chiang; Wu, Jason J.; Bahm, Valyn S.; Babilon, Robert, Method of treating actinic keratosis with 3.75% imiquimod cream.
  174. Miller, Richard L.; Tomai, Mark A.; Kedl, Ross M.; Zarraga, Isidro Angelo Eleazar; Ortiz, Ronnie; Stoesz, James D.; Wightman, Paul D., Methods and compositions for enhancing immune response.
  175. Gorden,Keith B.; Qiu,Xiaohong; Vasilakos,John P., Methods and compositions related to IRM compounds and Toll-like receptor 8.
  176. Mitra,Sumita B.; Shelburne,Charles E.; Tomai,Mark A., Methods for the treatment of periodontal disease.
  177. Miller, Richard L.; Lee, James H.; Fox, Terrance L., Methods for treating skin lesions.
  178. Miller, Richard L.; Lee, James H.; Owens, Mary L., Methods of improving skin quality.
  179. Gregory, Jefferson J.; Nordsiek, Michael T., Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy.
  180. Gregory, Jefferson J.; Nordsiek, Michael T., Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy.
  181. Merrill, Bryon A.; Haraldson, Chad A.; Kshirsagar, Tushar A.; Niwas, Shri, Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines.
  182. Gerster John F. (Woodbury MN) Knafla Roy T. (Woodbury MN), Olefinic 1H-imidazo(4,5-c)quinolin-4-amines.
  183. Gerster John F. (Woodbury MN), Olefinic 1H-imidazo[4,5-c]quinolin-4-amines.
  184. Gerster, John F.; Lindstrom, Kyle J.; Marszalek, Gregory J.; Merrill, Bryon A.; Mickelson, John W.; Rice, Michael J., Oxazolo, thiazolo and selenazolo [4,5-C]-quinolin-4-amines and analogs thereof.
  185. Gerster, John F.; Lindstrom, Kyle J.; Marszalek, Gregory J., Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof.
  186. Gerster, John F.; Lindstrom, Kyle J.; Marszalek, Gregory J.; Merrill, Bryon A.; Mickelson, John W.; Rice, Michael J., Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof.
  187. Gerster, John F.; Lindstrom, Kyle J.; Marszalek, Gregory J.; Merrill, Bryon A.; Mickelson, John W.; Rice, Michael J., Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof.
  188. Gerster,John F.; Lindstrom,Kyle J.; Marszalek,Gregory J., Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof.
  189. Gerster, John F.; Lindstrom, Kyle J.; Marszalek, Gregory J.; Merrill, Bryon A.; Mickelson, John W.; Rice, Michael J., Oxazolo, thiazolo and selenazolo [4,5-c]quinolin-4-amines and analogs thereof.
  190. Kshirsagar, Tushar A.; Lundquist, Jr., Gregory D.; Dellaria, Joseph F.; Radmer, Matthew R.; Zimmermann, Bernhard M., Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods.
  191. Lundquist, Jr., Gregory D.; Kshirsagar, Tushar A.; Heppner, Philip D., Oxime and hydroxylamine substituted thiazolo[4,5-c] ring compounds and methods.
  192. Kshirsagar, Tushar A.; Amos, David T.; Dellaria, Jr., Joseph F.; Heppner, Philip D.; Langer, Scott E.; Zimmermann, Bernhard M., Oxime substituted imidazo-containing compounds.
  193. Kshirsagar, Tushar A.; Lundquist, Gregory D.; Amos, David T.; Dellaria, Jr., Joseph F.; Zimmermann, Bernhard M.; Heppner, Philip D., Oxime substituted imidazoquinolines.
  194. Statham, Alexis S.; Henderson, Julie M.; Lundquist, Kevin G., Packaging for 1-(2-methylpropyl)-1H-imidazo[4,5-c] quinolin-4-amine-containing formulation.
  195. Leoni, Lorenzo; Maj, Roberto; Pattarino, Franco; Vecchio, Carlo, Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration.
  196. Leoni, Lorenzo; Maj, Roberto; Pattarino, Franco; Vecchio, Carlo, Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration.
  197. Skwierczynski, Raymond D.; Busch, Terri F.; Gust-Heiting, Amy L.; Fretland, Mary; Scholz, Matthew T., Pharmaceutical formulations comprising an immune response modifier.
  198. McInally, Thomas; Schulz, Håkan, Pharmaceutically acceptable salts of methyl (3-{ [[3-(6-amino- 2-butoxy-8-oxo-7,8-dihydro-9H-purin-9-yl) propyl] (3-morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy.
  199. Kshirsagar, Tushar A.; Griesgraber, George W.; Celebi, Azim A.; Heppner, Philip D., Piperazine, [1,4]Diazepane, [1,4]Diazocane, and [1,5]Diazocane fused imidazo ring compounds.
  200. Merli, Valeriano; Mantovani, Silvia; Bianchi, Stefano, Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via 1H-imidazo [4,5-C] quinolin-4-phthalimide intermediates.
  201. Merli,Valeriano; Mantovani,Silvia; Bianchi,Stefano, Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via 1H-imidazo [4,5-C] quinolin-4-phthalimide intermediates.
  202. Merli, Valeriano; Mantovani, Silvia; Bianchi, Stefano, Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via novel 1H-imidazo [4,5-c] quinolin-4-cyano and 1H-imidazo [4,5-c] quinolin-4-carboxamide intermediates.
  203. Merli,Valeriano; Mantovani,Silvia; Bianchi,Stefano, Preparation of 1H-imidazo[4,5-C] quinolin 4-amines via novel 1H-imidazo[4, 5-c] quinolin 4-cyano and 1H-imidazo[4,5-c] quinolin 4-carboxamide intermediates.
  204. Yu, Chongxi; Xu, Lina, Pro-drugs of NSAIAS with very high skin and membranes penetration rates and their new medicinal uses.
  205. Yu, Chongxi; Xu, Lina, Pro-drugs of NSAIAs with very high skin and membranes penetration rates and their new medicinal uses.
  206. Andre Jean-Denis (Pithiviers FRX) Lagin Daniel (Dadonville FRX), Process for 1H-imidazo[4,5-C]quinolines.
  207. Andre Jean-Denis (St. Paul MN) Lagain Daniel (St. Paul MN), Process for 1H-imidazo[4,5-c]quinolines.
  208. Lindstrom,Kyle J.; Dressel,Luke T., Process for imidazo[4,5-]pyridin-4-amines.
  209. Lindstrom, Kyle J.; Dressel, Luke T., Process for imidazo[4,5-c]pyridin-4-amines.
  210. Lindstrom, Kyle J.; Dressel, Luke T., Process for imidazo[4,5-c]pyridin-4-amines.
  211. Tarur, Venkatasubramanian Radhakrishnan; Kadam, Suresh Mahadev; Joshi, Anil Purushottam; Gavhane, Sachin Baban, Process for preparation of 4-amino-1-isobutyl-1H-imidazo[4,5-C]-quinoline (Imiquimod).
  212. Gerster, John F.; Crooks, Stephen L.; Lindstrom, Kyle J., Process for preparing 1-substituted, 2-substituted 1-H-imidazo(4,5-c)quinolin-4-amines.
  213. John F. Gerster ; Stephen L. Crooks ; Kyle J. Lindstrom, Process for preparing 1-substituted, 2-substituted 1H-imidazo[4, 5-c]quinoline-4-amines.
  214. Gerster, John F.; Crooks, Stephen L.; Lindstrom, Kyle J., Process for preparing 1-substituted, 2-substituted 1H-imidazo[4,5-C]quinolin-4-amines.
  215. Gerster, John F.; Lindstrom, Kyle J., Process for preparing 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines.
  216. Martin, Hughes; Ach, David; Toussaint, Clement; Dubois, Fabrice, Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine.
  217. Naddaka,Vladimir; Saeed,Shady; Montviliski,Dionne; Zelikovitch,Lior; Arad,Oded; Kaspi,Joseph, Process for preparing Imiquimod.
  218. Gerster John F. ; Lindstrom Kyle J., Process for preparing imidazoquinolinamines.
  219. Gerster John F. ; Lindstrom Kyle J., Process for preparing imidazoquinolinamines.
  220. Gerster, John F.; Lindstrom, Kyle J., Process for preparing imidazoquinolinamines.
  221. Gerster, John F.; Lindstrom, Kyle J., Process for preparing imidazoquinolinamines.
  222. Gerster, John F.; Lindstrom, Kyle J., Process for preparing imidazoquinolinamines.
  223. Gerster, John F.; Lindstrom, Kyle J., Process for preparing imidazoquinolinamines.
  224. Gerster,John F.; Lindstrom,Kyle J., Process for preparing imidazoquinolinamines.
  225. John F. Gerster ; Kyle J. Lindstrom, Process for preparing imidazoquinolinamines.
  226. Lindstrom Kyle J. (Houlton WI), Process for preparing tetrahdroimidazoquinolinamines.
  227. Egging, Elaine A.; Hammerbeck, David M.; Lee, James H., Prophylactic treatment of UV-induced epidermal neoplasia.
  228. Nordsiek, Michael T.; Balaji, Kodumudi S., Pump systems and methods for storing and dispensing a plurality of precisely measured unit-doses of imiquimod cream.
  229. Nordsiek, Michael T.; Balaji, Kodumudi S., Pump systems and methods for storing and dispensing a plurality of precisely measured unit-doses of imiquimod cream.
  230. Carson, Dennis A.; Cottam, Howard B.; Jin, Guangyi; Wu, Christina C. N.; Takabayashi, Kenji, Purine analogs.
  231. Abbott, Phillip; Bonnert, Roger Victor; McInally, Thomas; Thom, Stephen; Wada, Hiroki; Onuma, Satoshi, Purine derivatives.
  232. Hays, David S.; Danielson, Michael E.; Gerster, John F.; Niwas, Shri; Prince, Ryan B.; Kshirsagar, Tushar A.; Heppner, Philip D.; Moser, William H.; Moseman, Joan T.; Radmer, Matthew R.; Kavanagh, Maureen A.; Strong, Sarah A.; Bonk, Jason D., Pyrazolopyridines and analogs thereof.
  233. Hays, David S.; Danielson, Michael E.; Gerster, John F.; Niwas, Shri; Prince, Ryan B.; Kshirsagar, Tushar A.; Heppner, Philip D.; Moser, William H.; Moseman, Joan T.; Radmer, Matthew R.; Kavanagh, Maureen A.; Strong, Sarah A.; Bonk, Jason D., Pyrazolopyridines and analogs thereof.
  234. Hays, David S.; Danielson, Michael E.; Gerster, John F.; Niwas, Shri; Prince, Ryan B.; Kshirsagar, Tushar A.; Heppner, Philip D.; Moser, William H.; Moseman, Joan T.; Radmer, Matthew R.; Kavanagh, Maureen A.; Strong, Sarah A.; Bonk, Jason D., Pyrazolopyridines and analogs thereof.
  235. Bennett, Nicholas James; Thom, Stephen; McInally, Thomas, Pyrimidine derivatives and their use in the treatment of cancer and further diseases.
  236. Bennett, Nicholas J.; McInally, Thomas; Mochel, Tobias; Thom, Stephen; Tidén, Anna-Karin, Pyrimidline derivatives having immune modulating properties that act via TLR7 for the treatment of viral or allergic diseases and cancers.
  237. Bennett, Nicholas James; McInally, Thomas; Pimm, Austen; Isobe, Yoshiaki, Salts 756.
  238. Fink,Jason R.; Gorden,Keith B.; Gorski,Kevin S.; Gupta,Shalley K.; Qiu,Xiaohong; Vasilakos,John P., Selective modulation of TLR-mediated biological activity.
  239. Ylitalo, Caroline M.; Olson, Linda K. M.; Sahouani, Hassan; Vogel, Kim M., Silver ion releasing articles and methods of manufacture.
  240. Griesgraber, George W., Substituted 3,4,6,7-tetrahydro-5H-1,2a,4a,8-tetraazacyclopenta[cd]phenalenes and methods.
  241. Griesgraber, George W.; Kshirsagar, Tushar A.; Slania, Sarah J.; Danielson, Michael E., Substituted chiral fused [1,2]imidazo[4,5-.
  242. Griesgraber, George W.; Kshirsagar, Tushar A.; Slania, Sarah J.; Danielson, Michael E., Substituted chiral fused [1,2]imidazo[4,5-C] ring compounds.
  243. Kshirsagar, Tushar A.; Manske, Karl J.; Krepski, Larry R.; Moseman, Joan T.; Griesgraber, George W.; Slania, Sarah Johannessen; Langer, Scott E.; Heppner, Philip D., Substituted fused[1,2] imidazo[4,5-c] ring compounds and methods.
  244. Krepski, Larry R.; Dellaria, Jr., Joseph F.; Duffy, Daniel E.; Radmer, Matthew R.; Amos, David T., Substituted imidazo ring systems and methods.
  245. Krepski, Larry R.; Dellaria, Jr., Joseph F.; Duffy, Daniel E.; Radmer, Matthew R.; Amos, David T., Substituted imidazo ring systems and methods.
  246. Krepski, Larry R.; Dellaria, Jr., Joseph F.; Duffy, Daniel E.; Radmer, Matthew R.; Amos, David T., Substituted imidazo ring systems and methods.
  247. Rice, Michael J.; Haraldson, Chad A.; Gerster, John F.; Wurst, Joshua R.; Heppner, Philip D.; Merrill, Bryon A.; Kshirsagar, Tushar A., Substituted imidazoquinolines and imidazonaphthyridines.
  248. Stoermer, Doris; Dellaria, Jr., Joseph F.; Amos, David T.; Zimmermann, Bernhard M.; Dressel, Luke T.; Bonk, Jason D., Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines.
  249. Stoermer, Doris; Dellaria, Jr., Joseph F.; Amos, David T.; Zimmermann, Bernhard M.; Dressel, Luke T.; Bonk, Jason D.; Radmer, Matthew R., Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines.
  250. Stoermer, Doris; Dellaria, Jr., Joseph F.; Amos, David T.; Zimmermann, Bernhard M.; Dressel, Luke T.; Bonk, Jason D.; Radmer, Matthew R., Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines.
  251. Stoermer, Doris; Dellaria, Jr., Joseph F.; Amos, David T.; Zimmermann, Bernhard M.; Dressel, Luke T.; Bonk, Jason D.; Radmer, Matthew R., Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines.
  252. Stoermer, Doris; Dellaria, Jr., Joseph F.; Amos, David T.; Zimmermann, Bernhard M.; Dressel, Luke T.; Bonk, Jason D.; Radmer, Matthew R., Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines.
  253. Galatsis, Paul; Hayward, Matthew Merrill; Kormos, Bethany Lyn; Wager, Travis T.; Zhang, Lei; Stepan, Antonia Friederike; Henderson, Jaclyn Louise; Kurumbail, Ravi G.; Verhoest, Patrick Robert, Substituted pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitors.
  254. Crooks Stephen L. ; Lindstrom Kyle J. ; Merrill Bryon A. ; Rice Michael J., Sulfonamide and sulfamide substituted imidazoquinolines.
  255. Crooks, Stephen L.; Griesgraber, George W.; Lindstrom, Kyle J.; Merrill, Bryon A.; Rice, Michael J., Sulfonamide and sulfamide substituted imidazoquinolines.
  256. Crooks, Stephen L.; Lindstrom, Kyle J.; Merrill, Bryon A.; Rice, Michael J., Sulfonamide and sulfamide substituted imidazoquinolines.
  257. Griesgraber, George W., Sulfonamide and sulfamide substituted imidazoquinolines.
  258. Lindstrom, Kyle J., Sulfonamide and sulfamide substituted imidazoquinolines.
  259. Lindstrom,Kyle J., Sulfonamide and sulfamide substituted imidazoquinolines.
  260. Crooks, Stephen L.; Merrill, Byron A., Sulfonamide and sulfamide substituted imidazoquinolines and methods for the treatment of periodontal disease using these and other immune response modifiers.
  261. Crooks,Stephen L.; Merrill,Bryon A., Sulfonamide substituted imidazoquinolines.
  262. Crooks, Stephen L.; Griesgraber, George W.; Heppner, Philip D.; Merrill, Bryon A.; Roberts, Ralph R.; Wei, Ai-Ping, Sulfonamido ether substituted imidazoquinolines.
  263. Crooks, Stephen L.; Griesgraber, George W.; Heppner, Philip D.; Merrill, Bryon A.; Roberts, Ralph R.; Wei, Ai-Ping, Sulfonamido ether substituted imidazoquinolines.
  264. Griesgraber,George W.; Merrill,Bryon A.; Roberts,Ralph R.; Wei,Ai Ping, Sulfonamido ether substituted imidazoquinolines.
  265. Dellaria, Joseph F.; Haraldson, Chad A.; Heppner, Philip D.; Lindstrom, Kyle J.; Merrill, Bryon A., Sulfonamido substituted imidazopyridines.
  266. Dellaria, Joseph F.; Haraldson, Chad A.; Heppner, Philip D.; Lindstrom, Kyle J.; Merrill, Byron A., Sulfonamido substituted imidazopyridines.
  267. Lindstrom, Kyle J.; Heppner, Philip D., Sulfonamido substituted imidazopyridines.
  268. Hedenstrom, John C.; Jozwiakowski, Michael J.; Martinez, Mark; Phares, Kenneth R.; Trofatter, Jr., Kenneth, Systems and methods for treating a mucosal surface.
  269. Carson, Dennis A.; Takabayashi, Kenji; Cottam, Howard B.; Chan, Michael; Wu, Christina C. N., TLR agonists.
  270. Sluiman,Harm; Paternostro,Marcelo, Testing measurements.
  271. Tomai, Mark A.; Gullikson, Gary W.; Hammerbeck, David M.; Egging, Elaine A.; Reiter, Michael J.; Gram, Christopher D.; Vasilakos, John P., Therapeutic combinations and methods including IRM compounds.
  272. Bonk, Jason D.; Dellaria, Joseph F.; Merrill, Bryon A.; Radmer, Matthew R., Thioether substituted imidazoquinolines.
  273. Bonk, Jason D.; Dellaria, Joseph F.; Merrill, Bryon A.; Radmer, Matthew R., Thioether substituted imidazoquinolines.
  274. Dellaria, Joseph F.; Merrill, Bryon A.; Radmer, Matthew R., Thioether substituted imidazoquinolines.
  275. Dellaria, Joseph F.; Merrill, Bryon A.; Radmer, Matthew R., Thioether substituted imidazoquinolines.
  276. Dellaria,Joseph F.; Radmer,Matthew R., Thioether substituted imidazoquinolines.
  277. Dellaria,Joseph F.; Radmer,Matthew R.; Merrill,Bryon A., Thioether substituted imidazoquinolines.
  278. Carson, Dennis A.; Cottam, Howard B.; Hayashi, Tomoko; Chan, Michael, Toll-like receptor modulators and treatment of diseases.
  279. David, Sunil A.; Shukla, Nikunj M., Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds.
  280. David, Sunil A.; Shukla, Nikunj M., Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds.
  281. Lozinsky, Evgenia; Eilat, Eran, Topical compositions and methods of treatment of anorectal disorders.
  282. Lozinsky, Evgenia; Eilat, Eran, Topical compositions and methods of treatment of topical disorders.
  283. Wick Steven M. ; Schultz Helen Jensen ; Nelson Gregory R. ; Mitra Amit K. ; Berge Stephen M., Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-C]quinolin-4-amine.
  284. Flanigan, Peggy-Jean P.; Choi, Hye-ok, Transdermal delivery devices.
  285. Owens, Mary L.; Fox, Terrance L.; Ginkel, Angela M., Treatment for basal cell carcinoma.
  286. Owens, Mary L.; Fox, Terrance L.; Ginkel, Angela M., Treatment for basal cell carcinoma.
  287. Benninghoff, Bernd; Hengge, Ulrich R, Treatment for cutaneous metastases.
  288. Dellaria, Joseph F.; Haraldson, Chad A.; Heppner, Philip D.; Lindstrom, Kyle J.; Merrill, Bryon A., Urea substituted imidazopyridines.
  289. Dellaria, Joseph F.; Haraldson, Chad A.; Heppner, Philip D.; Lindstrom, Kyle J.; Merrill, Bryon A., Urea substituted imidazopyridines.
  290. Dellaria, Joseph F.; Haraldson, Chad A.; Lindstrom, Kyle J.; Merrill, Bryon A., Urea substituted imidazopyridines.
  291. Heppner, Philip D.; Lindstrom, Kyle J.; Merrill, Bryon A., Urea substituted imidazopyridines.
  292. Crooks, Stephen L.; Griesgraber, George W.; Heppner, Philip D.; Merrill, Bryon A., Urea substituted imidazoquinoline ethers.
  293. Crooks, Stephen L.; Griesgraber, George W.; Heppner, Philip D.; Merrill, Bryon A., Urea substituted imidazoquinoline ethers.
  294. Crooks,Stephen L.; Griesgraber,George W.; Heppner,Philip D.; Merrill,Bryon A., Urea substituted imidazoquinoline ethers.
  295. Crooks,Stephen L.; Griesgraber,George W.; Heppner,Philip D.; Merrill,Bryon A., Urea substituted imidazoquinoline ethers.
  296. Griesgraber, George W., Urea substituted imidazoquinoline ethers.
  297. Griesgraber,George W., Urea substituted imidazoquinoline ethers.
  298. Crooks, Stephen L.; Griesgraber, George W.; Lindstrom, Kyle J.; Merrill, Bryon A.; Rice, Michael J., Urea substituted imidazoquinolines.
  299. Crooks, Stephen L.; Griesgraber, George W.; Lindstrom, Kyle J.; Merrill, Bryon A.; Rice, Michael J., Urea substituted imidazoquinolines.
  300. Crooks, Stephen L.; Merrill, Bryon A.; Rice, Michael J., Urea substituted imidazoquinolines.
  301. Crooks, Stephen L.; Merrill, Bryon A.; Rice, Michael J., Urea substituted imidazoquinolines.
  302. Crooks, Stephen L.; Rice, Michael J., Urea substituted imidazoquinolines.
  303. Crooks,Stephen L.; Rice,Michael J., Urea substituted imidazoquinolines.
  304. Stöhr, Klaus; Dormitzer, Philip Ralph; Broeker, Michael, Vaccines for protecting against influenza.
  305. Stöhr, Klaus; Dormitzer, Philip; Del Giudice, Giuseppe, Vaccines for protecting against influenza.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로